Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy
- 55 Downloads
Patients with bone marrow transplant may present with acute, life-threatening complications which frequently (40% of our cases) require intensive care unit treatment and result in an increased mortality (76% in this series). In an attempt to reach a more objective prognostic assessment, we have analyzed those factors related to the worst outcome in the 25 patients with bone marrow transplant admitted into our intensive care unit. Respiratory failure was the most frequent complication (72%), with an 83% mortality. Graft-versus-host disease and neutropenia led to a greater number of infectious complications with a poor outcome. Failure of more than three organ systems, septic shock and mechanical ventilation were statistically associated with mortality (p<0.05), and all patients who required mechanical ventilation for more than seven days or needed intensive therapy for more than 10 days died. The presence of septic shock, multisystem failure and severe neutropenia on admission should be considered as initial indicators of a poor prognosis. More than 7 days of mechanical ventilation and an intensive care unit stay of more than 10 days could be critical points in the reassessment of the intensity and prolongation of treatment.
Key wordsAcute complications Bone marrow transplantation Intensive therapy
Unable to display preview. Download preview PDF.
- 3.Bowden AR, Meyers JD (1985) Infectious complications following marrow transplantation. Plasma Ther Transfus Technol 6:285Google Scholar
- 6.Dominguez de Villota V, Algora A, Rubio JJ, Mosquera JM, Galdos P, Diez-Balda V (1981) Septicaemia in a medical intensive care unit. Clinical, biochemical and microbiological data of 109 cases. Intensive Care Med 9:109Google Scholar
- 9.Goldman JM, Baughan ASJ, McCarthy DM, Worsely AM, Hows JM, Gordon-Smith EC, Catovsky D, Batchelor JR, Goolden AWG, Galton DAG (1983) Transplante medular en pacientes con LMC en fase crónica. Lancet 13Google Scholar
- 11.Kadota RP, Smithson WA (1982) Bone marrow transplantation for diseases of childhood. Mayo Clin Proc 57:668Google Scholar
- 15.Rozman C (1983) Trasplante de médula osea. Med Int 1:85Google Scholar
- 17.Storb R, Deeg JH, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner D, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED (1986) Methotrexate and cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729PubMedGoogle Scholar
- 18.Storb R, Prentice RL, Buckner CD, Clift RA, Appelbaum F, Deeg J, Doney K, Hansen JA, Mason M, Sanders JE, Singer J, Sullivan KM, Witherspoon RP, Thomas ED (1983) Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. N Engl J Med 308:302PubMedGoogle Scholar
- 22.Winston JD, Gale RP, Meyer DV, Young LS and the UCLA Bone Marrow Transplantation Group (1979) Infectious complications of human bone marrow transplantation. Medicine (Baltimore) 58:1Google Scholar